
Relevate Health
Independent
Address
4270 Ivy Pointe Blvd, Suite 220
Cincinnati, OH, 45245
Web Address
Year Founded
2007
North American Revenue 2022
Full-time Employees 2022
Number of clients 2022
Offices
North America
4
Locations
Cincinnati, OH
Braintree, MA
Berkeley Heights, NJ
Dallas, TX
Executives & Senior Management
Senior Management
Tim Pantello
Megan Jones
Chief Operations Officer
Clay Romweber
Chief Revenue Officer
Julie Granberry
Chief Insights and Strategy Officer
Roy Wilschut
Chief Product Officer
Sabrina Ingram
VP, People Operations
Louis-Philippe Cavallo
Chief Financial Officer
Agency 100 T-Shirt

Capabilities/Services Offered
Professional
Consumer
OTC
Direct Marketing
Media Planning
Public Health
Data/Analytics
Digital
New Services
Implemented a robust metrics plan to garner PLD and ROI for our engagement solutions to add certainty and help customers see the results. Unified our technology and data implementation to create an "integrated ecosystem." This way, all data from the disparate products and solutions flow into a single, unified database, continuing to drive our holistic understanding but also helping to create fully integrated omnichannel engagements when implementing multiple programs. In addition to the following solution examples, we offered bundled solutions to better meet our clients' omnichannel needs. We now have 13 unique solutions and 6 bundled packages. Treatment Perspectives Key Account Messaging Programmatic content that reaches specialty-relevant HCPs at their point of practice (key accounts) using a blend of active and historical search data and unified identifiers. Applicable when location is known, yet other means of contact are not available or practical. Treatment Perspectives EHR HCP Messaging Highly targeted brand content is delivered within the HCP's EHR workflow using real-time data based on ICD-100, NDC-, or CPT-based business rules. Messages can be creative, text, or financial. Treatment Perspectives Interactive Quiz Highly relevant content is designed to catch the attention of targeted HCPs in the form of interactive questions followed by a survey page that reinforces the answers. An email driver is deployed by Relevate Health each month to keep the experience fresh. mChat Field force representatives host a peer-to-peer engagement that leverages the brand's trained speakers to engage with their targeted HCPs. The HCP can select topics and schedules through a mChat operator who supports the rep. Over the past few years, we have built out our data infrastructure teams and tech. With that as our backbone, this year, we further built our in-house decision science team and ElevatedRelevance Decision Engine to drive strategy and measure results. This foundation informs all our solutions and helps our agency services team develop creative solutions founded on data-driven customer understanding and insight. 2022 was a big year of integration and acceleration of the investments and acquisitions we have made over the past couple of years. We integrated all operations from the two acquisitions into a comprehensive delivery team with shared operational tools for transparency, ease, and speed. Customer success unified to improve client experience across our mix of solutions and services. In addition, we unified our technology and data implementation to create an "integrated ecosystem." This way, all data from the disparate products and solutions flow into a single, unified database, continuing to drive our holistic understanding but also helping to create fully integrated omnichannel engagements when implementing multiple programs.
New Roles
Roles Added
4
Roles
Roy Wilschut, Chief Product Officer
Sabrina Ingram, VP, People Operations
Julie Granberry, Chief Insights and Strategy Officer
George Griffith, EVP, Omnichannel Strategy
Client Roster
Mallinckrodt / Acthar
Sanofi / Adacel
Sanofi / Elitek
Sanofi / Fluzone
Sanofi / Jevtana
Sanofi / Menquadfi
Sanofi / Sarclisa
Seagen, Inc. / Adcetris
Seagen, Inc. / Tukysa
Tris Pharma, Inc / ADHD
Akebia Therapeutics, Inc. / Auryxia
Teva Pharmaceuticals USA, Inc. / Austedo
Teva Pharmaceuticals USA, Inc. / Digihaler
Blue Earth / Axumin
GlaxoSmithKline LLC / Benlysta
GlaxoSmithKline LLC / Momelotinib
GlaxoSmithKline LLC / RSV
GlaxoSmithKline LLC / Shingrix
Viatris / Biosimilars
Viatris / Fulphila
Viatris / Ogivri
Viatris / Tobipodhaler
Pfizer Inc. / Brektovi/Mektovi
Pfizer Inc. / Ibrance
Pfizer Inc. / Paxlovid
Pfizer Inc. / Vaccines
Pfizer Inc. / Internal Medicine
Pfizer Inc. / Xtandi
ViiV Healthcare Company / Cabenuva
ViiV Healthcare Company / Dovato
ViiV Healthcare Company / Rukobia
AstraZeneca Pharmaceuticals LP / Calquence
AstraZeneca Pharmaceuticals LP / Enhertu
AstraZeneca Pharmaceuticals LP / Farixga
AstraZeneca Pharmaceuticals LP / Imfinizi
AstraZeneca Pharmaceuticals LP / Lynparza
AstraZeneca Pharmaceuticals LP / Tagrisso
Bristol Myers Squibb / Camzyos
Bristol Myers Squibb / Inrebic
Bristol Myers Squibb / Mavacamtem
Bristol Myers Squibb / Onureg
Bristol Myers Squibb / Opdivo
Bristol Myers Squibb / Reblozyl
Bristol Myers Squibb / Zeposia
Intra Cellular Therapies / Caplyta
GE Healthcare / Cerianna
Exact Sciences / Cologuard
Exact Sciences / Precision Oncology
Boehringer Ingelheim Pharmaceuticals, Inc / COPD
Boehringer Ingelheim Pharmaceuticals, Inc / Jardiance
Genentech / Corporate
Genentech / Mosunetuzumab
Genentech / Phesgo
Kyowa Kirin, Inc. / Corporate
Multiple Myeloma Research Foundation, Inc. / Corporate
G1 Therapeutics / Cosela
Janssen Biotech Inc. / Darzalex
Janssen Biotech Inc. / Erleada
Janssen Biotech Inc. / Imbruvica
Janssen Biotech Inc. / Invokana
Janssen Biotech Inc. / Ponesimod
Janssen Biotech Inc. / Rybrevant
Janssen Biotech Inc. / Simponi ARIA
Janssen Biotech Inc. / Spravato
Janssen Biotech Inc. / Tremfya
Janssen Biotech Inc. / Uptravi
Takeda Pharmaceuticals / Entyvio
Regeneron Healthcare Solutions, Inc. / Eveeza
Regeneron Healthcare Solutions, Inc. / Libtayo
AVEO Pharmaceuticals, Inc. / Fotivda
Neurocine Biosciences, Inc. / Ingrezza
Merck & Company / Januvia
Merck & Company / Keytruda
Merck & Company / Steglatro
Merck & Company / Verquovo
Otsuka America Pharmaceutical / Jynarque
Novartis Pharmaceuticals Corporation / Kesimpta
Novartis Pharmaceuticals Corporation / Sabatolimab
Novartis Pharmaceuticals Corporation / Xiidra
Amgen U.S.A. Inc. / Kypolis
Amgen U.S.A. Inc. / Nplate
Amgen U.S.A. Inc. / Otezla
Amgen U.S.A. Inc. / Repatha
Genmab / Large B-Cell Lymphoma Team
Bayer HealthCare Pharmaceuticals, Inc / Nubeqa
Biohaven / Nurtec
Novo Nordisk, Inc. / Ozempic
Novo Nordisk, Inc. / Rybelsus
Novo Nordisk, Inc. / Wegovy
EMD SERONO / Rebif
Clovis Oncology, Inc. / Rubraca
Prasco Laboratories / Spritam
Edwards Lifesciences / THV
Gilead Sciences, Inc. / Trodelvy
Gilead Sciences, Inc. / Yescarta / Tecartus
Helsinn Therapeutics / Truseltiq
Horizon Therapeutics / Uplizna
PLx Pharma / Vazalore
AbbVie Inc. / Venclexta
Alkermes / Vivitrol
Boston Scientific / Watchman
Astellas Pharma US, Inc / Women's Health
Astellas Pharma US, Inc / Xtandi
Collegium Pharmaceuticals / Xtampza
Amarin / Vascepa
Ferring / Clenpiq
Fresenius Kabi / IDACIO
Fresenius Kabi / tocilizumab
Incyte / Jakafi
Growth
2022 Growth from Existing Clients
1%
2022 Growth from New Clients
25%
Trends and Challenges
Talent acquisition/retention
Managing growth
Getting an audience, virtually or otherwise, with HCPs
Keeping up with pace of innovation
Client losses in the wake of pharma M&A
Replenishing new-business pipeline
Procurement-related issues
Network relationships/agency consolidation
Further diversification of services
Healthcare Marketing Trends
More personalization of communications
Need to create more/better content/experiences
Industry consolidation
Intensified focus on analytics/ROI/measurement
Decreased impact of sales forces
Programs that go “beyond the pill”
Evolution of EHRs
Emphasis on specialty drugs/high-science categories
Adopting a data-science culture
More digital experimentation
Working from home
Creative Samples


